http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2014147388-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B65D85-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J1-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 |
| filingDate | 2013-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2014147388-A |
| titleOfInvention | LARGE VOLUME HEMCITABIN MEDICINAL FORM AND INFORMATION KIT INCLUDING MEDICINAL FORM |
| abstract | 1. Dosage form of large volume gemcitabine for infusion containing a stable solution of a large volume of gemcitabine or its pharmaceutically acceptable salt in an aqueous solvent ready to be infused, filled in a large volume infusion container. The dosage form of gemcitabine according to claim 1, characterized in that the infusion container is a polymeric single-chamber container that does not contain polyvinyl chloride. 3. The dosage form of gemcitabine according to claim 1, characterized in that the aqueous solvent does not contain cosolvents. A dosage form of gemcitabine according to claim 1, characterized in that the solvent has a concentration of gemcitabine from 5 mg / ml to 20 mg / ml. A kit comprising a large volume infusion dosage form containing a ready-to-infusion stable solution of a large volume of gemcitabine or a pharmaceutically acceptable salt thereof in an aqueous solvent and filled into a large volume polymer infusion container coated with an additional packaging. 6. A kit according to claim 5, characterized in that gemcitabine or a pharmaceutically acceptable salt thereof is present at a concentration of 10 mg / ml and is poured into volumes from 100 ml to 300 ml. A kit according to claim 6, characterized in that the infusion container contains 160 ml of a stable solution of gemcitabine or a pharmaceutically acceptable salt thereof in an aqueous solvent and provides a dose of 1600 mg of gemcitabine hydrochloride per container. A kit according to claim 6, characterized in that the infusion container contains 170 ml of a stable solution of gemcitabine or a pharmaceutically acceptable salt thereof in an aqueous solvent and provides a dose of 1700 mg of gemcitabine hydrochloride per container. A kit according to claim 6, characterized in that |
| priorityDate | 2012-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 19.